Skip to main content

Advertisement

SpringerLink
Log in

Evaluation and management of aortic valve and root disease

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Aortic valve disease manifests in the form of stenosis, regurgitation, or some combination, yielding either excessive afterload and/or excessive preload on the left ventricle. Aortic root disease may affect valvular function, causing regurgitation; may simply be coexistent with stenotic aortic valvular disease; or may exist despite normal aortic valve function. Indications for intervening on aortic valve or root disease are determined by the presence of symptoms, by the pathology’s impact on left ventricular function, or by the inherent risk of aortic catastrophe (dissection, disruption, or sudden death). Aortic valvular and root diseases are primarily treated by surgical replacement of the pathologic structures. Mechanical aortic valve replacement has long-term durability but requires continuous anticoagulation. Bioprostheses do not require anticoagulation but have more limited durability. Valve-sparing aortic root replacement and aortic valve repair offer the potential for indefinite durability without the need for anticoagulation but are technically more difficult to perform and require more stringent selection criteria based on determining the reparability of an aortic valve. Emerging percutaneous valve technologies offer new hope for patients who are not candidates for aortic valve surgery, but the applicability and durability of percutaneous aortic valves are not yet known. Timely and appropriate intervention in aortic valve and root disease can result in the restoration of a normal life span for patients with aortic valvular and/or root disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Da Vinci L: Corpus of the Anatomical Studies in the Collection of Her Majesty the Queen of Windsor Castle. London: Harcourt Brace Jovanovich; 1983.

    Google Scholar 

  2. Robicsek F: Leonardo da Vinci and the sinuses of Valsalva. Ann Thorac Surg 1991, 52:328–335.

    Article  PubMed  CAS  Google Scholar 

  3. Yacoub MH, Kilner PJ, Birks EJ, Misfeld M: The aortic outflow and root: a tale of dynamism and crosstalk. Ann Thorac Surg 1999, 68(3 Suppl):S37–S43.

    Article  PubMed  CAS  Google Scholar 

  4. Dare AJ, Veinot JP, Edwards WD, et al.: New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Human Pathol 1993, 24:1330–1338.

    Article  CAS  Google Scholar 

  5. Otto CM, Burwash IG, Legget ME, et al.: Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997, 95:2262–2270.

    PubMed  CAS  Google Scholar 

  6. Zoghbi WA, Enriquez-Sarano M, Foster E, et al.: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003, 16:777–802.

    Article  PubMed  Google Scholar 

  7. Brener SJ, Duffy CI, Thomas JD, Stewart WJ: Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol Feb 1995, 25:305–310.

    Article  CAS  Google Scholar 

  8. Faggiano P, Aurgiemma GP, Rusconi C, Gaasch WH: Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am Heart J 1996, 132(2 Pt 1):408–417.

    Article  PubMed  CAS  Google Scholar 

  9. Sasayama S, Ross J Jr, Franklin D, et al.: Adaptations of the left ventricle to chronic pressure overload. Circulation Res 1976, 38:172–178.

    PubMed  CAS  Google Scholar 

  10. Gaasch WH: Left ventricular radius to wall thickness ratio. Am J Cardiol 1979, 43:1189–1194.

    Article  PubMed  CAS  Google Scholar 

  11. Spann JF, Bove AA, Natarajan G, Kreulen T: Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980, 62:576–582.

    PubMed  CAS  Google Scholar 

  12. Iivanainen AM, Lindroos M, Tilvis R, et al.: Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996, 78:97–101.

    Article  PubMed  CAS  Google Scholar 

  13. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ: The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990, 15:1012–1017.

    PubMed  CAS  Google Scholar 

  14. Pellikka PA, Sarano ME, Nishimura RA, et al.: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005, 111:3290–3295.

    Article  PubMed  Google Scholar 

  15. Taniguchi K, Kawamaoto T, Kuki S, et al.: Left ventricular myocardial remodeling and contractile state in chronic aortic regurgitation. Clin Cardiol 2000, 23:608–614.

    Article  PubMed  CAS  Google Scholar 

  16. Schwarz F, Baumann P, Manthey J, et al.: The effect of aortic valve replacement on survival. Circulation 1982, 66:1105–1110.

    PubMed  CAS  Google Scholar 

  17. Bonow RO, Carabello BA, Kanu C, et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84–e231.

    Article  PubMed  Google Scholar 

  18. Borger MA, Preston M, Ivanov J, et al.: Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 2004, 128:677–683.

    Article  PubMed  Google Scholar 

  19. Ergin MA, Spielvogel D, Apaydin A, et al.: Surgical treatment of the dilated ascending aorta: when and how? Ann Thorac Surg 1999, 67:1834–1839; discussion 1853–1856.

    Article  PubMed  CAS  Google Scholar 

  20. Svensson LG, Kim KH, Lytle BW, Cosgrove DM: Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg 2003, 126:892–893.

    Article  PubMed  Google Scholar 

  21. Davies RR, Goldstein LJ, Coady MA, et al.: Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002, 73:17–27; discussion 27–28.

    Article  PubMed  Google Scholar 

  22. Devlin RK, Andrews MM, von Reyn CF: Recent trends in infective endocarditis: influence of case definitions. Curr Opin Cardiol 2004, 19:134–139.

    Article  PubMed  Google Scholar 

  23. Leyh RG, Knobloch K, Hagl C, et al.: Replacement of the aortic root for acute prosthetic valve endocarditis: prosthetic composite versus aortic allograft root replacement. J Thorac Cardiovasc Surg 2004, 127:1416–1420.

    Article  PubMed  Google Scholar 

  24. Lytle BW, Priest BP, Taylor PC, et al.: Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996, 111:198–207; discussion 207–210.

    Article  PubMed  CAS  Google Scholar 

  25. Watanabe G, Haverich A, Speier R, et al.: Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg 1994, 107:171–177.

    PubMed  CAS  Google Scholar 

  26. Rajamannan NM, Gersh B, Bonow RO: Calcific aortic stenosis: from bench to the bedside—emerging clinical and cellular concepts. Heart 2003, 89:801–805.

    Article  PubMed  Google Scholar 

  27. Verma S, Szmitko PE, Fedak PW, et al.: Can statin therapy alter the natural history of bicuspid aortic valves? Am J Physiol 2005, 288:H2547–H2549.

    CAS  Google Scholar 

  28. Stewart BF, Siscovick D, Lind BK, et al.: Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997, 29:630–634.

    Article  PubMed  CAS  Google Scholar 

  29. Caira FC, Stock SR, Gleason TG, et al.: Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006, 47:1707–1712.

    Article  PubMed  CAS  Google Scholar 

  30. Weiss RM, Ohashi M, Miller JD, et al.: Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006, 114:2065–2069.

    Article  PubMed  Google Scholar 

  31. Chan KL, Teo K, Tam J, Dumesnil JG: Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Am Heart J 2007, 153:925–931.

    Article  PubMed  CAS  Google Scholar 

  32. Moura LM, Ramos SF, Zamorano JL, et al.: Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007, 49:554–561.

    Article  PubMed  CAS  Google Scholar 

  33. Rossebo AB, Pedersen TR, Allen C, et al.: Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol 2007, 99:970–973.

    Article  PubMed  CAS  Google Scholar 

  34. Rajamannan NM: Calcific aortic stenosis: a disease ready for prime time. Circulation 2006, 114:2007–2009.

    Article  PubMed  Google Scholar 

  35. Rajamannan NM, Bonow RO, Rahimtoola SH: Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007, 4:254–262.

    Article  PubMed  CAS  Google Scholar 

  36. Newby DE, Cowell SJ, Boon NA: Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? Heart 2006, 92:729–734.

    Article  PubMed  CAS  Google Scholar 

  37. Shavelle DM: Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis? Heart 2005, 91:1257–1259.

    Article  PubMed  CAS  Google Scholar 

  38. Evangelista A, Tornos P, Sambola A, et al.: Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005, 353:1342–1349.

    Article  PubMed  CAS  Google Scholar 

  39. Scognamiglio R, Rahimtoola SH, Fasoli G, et al.: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994, 331:689–694.

    Article  PubMed  CAS  Google Scholar 

  40. Plante E, Lachance D, Gaudreau M, et al.: Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation 2004, 110:1477–1483.

    Article  PubMed  CAS  Google Scholar 

  41. Rahimtoola SH: Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994, 23:1076–1078.

    Article  PubMed  CAS  Google Scholar 

  42. Bach DS, Kon ND, Dumesnil JG, et al.: Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann Thorac Surg 2005, 80:480–486; discussion 486–487.

    Article  PubMed  Google Scholar 

  43. John A, Khan Z, Kuo J, et al.: A prospective randomized comparison of Medtronic Mosaic and Carpentier-Edwards-SAV in the aortic position: an interim report. J Heart Valve Dis 2006, 15:441–445.

    PubMed  Google Scholar 

  44. Gao G, Wu Y, Grunkemeier GL, et al.: Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol 2004, 44:384–388.

    Article  PubMed  Google Scholar 

  45. Taylor KM: The Edinburgh heart valve study. Heart 2003, 89:697–698.

    Article  PubMed  CAS  Google Scholar 

  46. Hammermeister K, Sethi GK, Henderson WG, et al.: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000, 36:1152–1158.

    Article  PubMed  CAS  Google Scholar 

  47. Kulik A, Bedard P, Lam BK, et al.: Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg 2006, 30:485–491.

    Article  PubMed  Google Scholar 

  48. Bernal JM, Rabasa JM, Lopez R, et al.: Durability of the Carpentier-Edwards porcine bioprosthesis: role of age and valve position. Ann Thorac Surg 1995, 60(2 Suppl):S248–S252.

    Article  PubMed  CAS  Google Scholar 

  49. Minami K, Zittermann A, Schulte-Eistrup S, et al.: Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1516 patients. Ann Thorac Surg 2005, 80:1699–1705.

    Article  PubMed  Google Scholar 

  50. Minami K, Boethig D, Mirow N, et al.: Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors. J Heart Valve Dis 2000, 9:112–122.

    PubMed  CAS  Google Scholar 

  51. Pelletier LC, Carrier M, Leclerc Y, Dyrda I: The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600 patients. Ann Thorac Surg 1995, 60(2 Suppl):S297–S302.

    PubMed  CAS  Google Scholar 

  52. Gleason TG, David TE, Coselli JS, et al.: St. Jude Medical Toronto biologic aortic root prosthesis: early FDA phase II IDE study results. Ann Thorac Surg 2004, 78:786–793.

    Article  PubMed  Google Scholar 

  53. Knott-Craig CJ, Elkins RC, Santangelo KL, et al.: Aortic valve replacement: comparison of late survival between autografts and homografts. Ann Thorac Surg 2000, 69:1327–1332.

    Article  PubMed  CAS  Google Scholar 

  54. Doty JR, Salazar JD, Liddicoat JR, et al.: Aortic valve replacement with cryopreserved aortic allograft: ten-year experience. J Thorac Cardiovasc Surg 1988, 115:371–379; discussion 379–380.

    Article  Google Scholar 

  55. Kirklin JK, Smith D, Novick W, et al.: Long-term function of cryopreserved aortic homografts. A ten-year study. J Thorac Cardiovasc Surg 1993, 106:154–165; discussion 165–166.

    PubMed  CAS  Google Scholar 

  56. Takkenberg JJ, Eijkemans MJ, van Herwerden LA, et al.: Prognosis after aortic root replacement with cryopreserved allografts in adults. Ann Thorac Surg 2003, 75:1482–1489.

    Article  PubMed  Google Scholar 

  57. Luciani GB, Casali G, Favaro A, et al.: Fate of the aortic root late after Ross operation. Circulation 2003, 108(Suppl 1):II61–II67.

    Article  PubMed  Google Scholar 

  58. Elkins RC, Lane MM, McCue C, Ward KE: Pulmonary autograft root replacement: mid-term results. J Heart Valve Dis 1999, 8:499–503; discussion 503–506.

    PubMed  CAS  Google Scholar 

  59. Stelzer P, Weinrauch S, Tranbaugh RF: Ten years of experience with the modified Ross procedure. J Thorac Cardiovasc Surg 1998, 115:1091–1100.

    Article  PubMed  CAS  Google Scholar 

  60. Gleason TG: Current perspective on aortic valve repair and valve-sparing aortic root replacement. Semin Thorac Cardiovasc Surg 2006, 18:154–164.

    Article  PubMed  Google Scholar 

  61. Casselman FP, Gillinov AM, Akhrass R, et al.: Intermediate-term durability of bicuspid aortic valve repair for prolapsing leaflet. Eur J Cardiothorac Surg 1999, 15:302–308.

    Article  PubMed  CAS  Google Scholar 

  62. Nash PJ, Vitvitsky E, Li J, et al.: Feasibility of valve repair for regurgitant bicuspid aortic valves—an echocardiographic study. Ann Thorac Surg 2005, 79:1473–1479.

    Article  PubMed  Google Scholar 

  63. David TE, Feindel CM, Webb GD, et al.: Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg 2006, 132:347–354.

    Article  PubMed  Google Scholar 

  64. David TE, Ivanov J, Armstrong S, et al.: Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta. Ann Thorac Surg 2002, 74:S1758–S1761; discussion S1792–S1799.

    Article  PubMed  Google Scholar 

  65. Gleason TG: Heritable disorders predisposing to aortic dissection. Semin Thorac Cardiovasc Surg. 2005, 17:274–281.

    Article  PubMed  Google Scholar 

  66. Ye J, Cheung A, Lichtenstein SV, et al.: Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 2007, 31:16–21.

    Article  PubMed  Google Scholar 

  67. Lichtenstein SV, Cheung A, Ye J, et al.: Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006, 114:591–596.

    Article  PubMed  Google Scholar 

  68. Grube E, Laborde JC, Gerckens U, et al.: Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006, 114:1616–1624.

    Article  PubMed  Google Scholar 

  69. Cribier A, Eltchaninoff H, Bash A, et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006–3008.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Suite C-718, 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    Thomas G. Gleason

Authors
  1. John B. de Graft-Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas G. Gleason
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas G. Gleason.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Graft-Johnson, J.B., Gleason, T.G. Evaluation and management of aortic valve and root disease. Curr Treat Options Cardio Med 9, 465–472 (2007). https://doi.org/10.1007/s11936-007-0041-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-007-0041-2

Keywords

Search

Navigation